We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Rogan Medical Changes Name to Rogan-Delft

By HospiMedica staff writers
Posted on 10 Jan 2003
In a move that marks the new direction of Rogan Medical Systems B.V. (Veenendaal, The Netherlands), the company has changed its name to Rogan-Delft B.V.

For the past two years, Rogan has changed its strategy from selling hardware and software products to selling only software and is known for its HyperPACS product line. The company has since expanded its PACS installations throughout the world via distributors and resellers. During this time, Delft Instruments N.V. (Delft, The Netherlands) took a majority position in the company. The new name reflects this development.

The name Rogan-Delft is also designed to emphasize the company's integration with the medical group of Delft Instruments and Rogan's intention to position itself as part of the new Delft Diagnostic Imaging Group within Delft Instruments. Rogan-Delft's new web address is www.rogan-medical.com.




Related Links:
Delft Instruments
Rogan-Delft
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
New
Radiation Safety Barrier
RayShield Intensi-Barrier

Channels

Surgical Techniques

view channel
Image: The novel approach combining MRI, fluid dynamics, and custom algorithms predicts brain cancer recurrence sites (photo courtesy of AdobeStock)

Novel Method Uses Interstitial Fluid Flow to Predict Where Brain Tumor Can Grow Next

Glioblastoma is one of the most aggressive brain cancers, with patients surviving on average only 15 months after diagnosis. Surgery and radiation can temporarily control the tumor, but the disease almost... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more